Results 231 to 240 of about 24,482,269 (284)

Efficacy and Safety of Fixed‐Dose Combinations of Sitagliptin and Empagliflozin as Add‐On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double‐Blind, Multi‐Centre, Placebo‐Controlled, Phase III Trial

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Type 2 diabetes mellitus (T2DM) is a progressive, multi‐organ disorder that often requires intensive combination therapy. This Phase III, randomised, double‐blind, placebo‐controlled study evaluated the efficacy and safety of two fixed‐dose combinations (FDCs) of sitagliptin 100 mg with empagliflozin 10 mg (DW1026C1) or ...
Soo Lim, Tae Nyun Kim, Ji Oh Mok, Choon Hee Chung, You Cheol Hwang, Ho Chan Cho, Jong Chul Won, Eonju Jeon, Eun Seok Kang, Ki Young Lee, Chong Hwa Kim, Soo Heon Kwak, Cheol Young Park, Kang Seo Park, Sang Yong Kim, Jae Hyuk Lee, Soon Hee Lee, Dong Hyeok Cho, Hyuk‐Sang Kwon, Kyung Ah Han   +19 more
wiley   +1 more source

Implementation Science Symposium: Moving the Needle in Epilepsy Care. [PDF]

Epilepsy Curr
Rubinos C, Ostendorf A, Freedman D.
europepmc   +1 more source

Artificial Intelligence in Type 1 Diabetes Management: A Scoping Review of Randomised Controlled Trials

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Artificial intelligence is emerging in healthcare systems. In type 1 diabetes, AI‐enabled tools are increasingly used to support nutrition assessment and insulin decision‐making, yet their clinical utility and safety remain unclear. Methods The study aims to identify and map the evidence on the clinical utility of AI‐based diabetes ...
Yucen Wu, Jun Pang, Shaoyong Xu, Lalantha Leelarathna, Aaron M. Lett   +4 more
wiley   +1 more source

Frontline Therapy in Diffuse Large B‐Cell Lymphoma: Evolving Standards, Biological Insights, and Future Directions

European Journal of Haematology, EarlyView.
ABSTRACT Diffuse large B‐cell lymphoma (DLBCL) remains the most common aggressive lymphoma, representing a biologically heterogeneous disease with diverse clinical behaviors. For more than two decades, R‐CHOP has been the cornerstone of frontline treatment, curing approximately two‐thirds of patients.
Mamdouh Skafi, Santino Caserta, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Maria Eugenia Alvaro, Fortunato Morabito, Enrica Antonia Martino, Massimo Gentile   +12 more
wiley   +1 more source

Development of dual acting selenium-doped hydroxyapatite nanoparticles with platinum-bisphosphonate complexes for bone cancer therapy. [PDF]

RSC Adv
Barbanente A, Di Cosola AM, Rizzi F, Depalo N, Comparelli R, Castaldo R, Fanizza E, Papadia P, Pacifico C, Niso M, Margiotta N.   +10 more
europepmc   +1 more source

Proactive and creative personality as predictors of student engagement and innovative behavior among Chinese university students. [PDF]

Front Psychol
Meng WY, Kang KW, Quan CL.
europepmc   +1 more source

[Social security burden due to work-related disability due to kidney failure]. [PDF]

Rev Med Inst Mex Seguro Soc
Torres-Toledano M, Molina-Domínguez T, Bautista-De Anda R, Cortés-Sanabria L, Granados-García V, Cueto-Manzano A.   +5 more
europepmc   +1 more source